Published in Arthritis Care Res (Hoboken) on May 01, 2014
Finding Ways to Lift Barriers to Care for Chronic Pain Patients: Outcomes of Using Internet-Based Self-Management Activities to Reduce Pain and Improve Quality of Life. Pain Res Manag (2016) 0.78
The educational needs of people with systemic sclerosis: a cross-sectional study using the Dutch version of the Educational Needs Assessment Tool (D-ENAT). Rheumatol Int (2015) 0.75
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 12.07
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum (2011) 6.28
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest (2007) 4.96
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis (2011) 4.15
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report. J Rheumatol (2009) 2.89
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 2.86
Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum (2007) 2.80
Dating the "window of therapeutic opportunity" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset. J Rheumatol (2004) 2.28
Randomized evaluation of a web based interview process for urology resident selection. J Urol (2012) 1.95
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum (2010) 1.94
A delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol (2013) 1.77
Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. Pediatr Diabetes (2003) 1.74
Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis. J Rheumatol (2009) 1.63
Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury. J Pharmacol Exp Ther (2014) 1.61
Effect of managed care on emergency department use in an uninsured population. Ann Emerg Med (2004) 1.51
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol (2012) 1.48
Systemic sclerosis - continuing progress in developing clinical measures of response. J Rheumatol (2007) 1.46
Acute injection site reaction to intraarticular etanercept administration. Arthritis Rheum (2003) 1.46
Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. J Rheumatol (2007) 1.43
Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. Arthritis Rheum (2009) 1.42
Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) (2012) 1.41
Satisfaction and access to clinical care in a rheumatology clinic at a large urban medical center. J Clin Rheumatol (2012) 1.40
Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis. Clin Immunol (2011) 1.39
Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum (2011) 1.35
The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials. J Rheumatol (2009) 1.32
Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum (2004) 1.29
Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford) (2009) 1.27
Internet-based training in a practice-based research network consortium: a report from the Primary Care Multiethnic Network (PRIME Net). J Am Board Fam Med (2009) 1.27
Prepared patients: internet information seeking by new rheumatology patients. Arthritis Rheum (2008) 1.27
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. Ann Rheum Dis (2007) 1.25
Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol (2008) 1.23
Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Arthritis Rheum (2011) 1.22
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial. Ann Rheum Dis (2011) 1.17
Early detection and management of pulmonary arterial hypertension. Eur Respir Rev (2012) 1.17
Long-term safety of pegloticase in chronic gout refractory to conventional treatment. Ann Rheum Dis (2012) 1.15
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial. Arthritis Rheum (2008) 1.15
Diagnostic and management trends of giant cell arteritis: a physician survey. J Rheumatol (2005) 1.15
Community health workers and medicaid managed care in New Mexico. J Community Health (2012) 1.15
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes (2012) 1.13
Prevalence and correlates of mental disorders among Native American women in primary care. Am J Public Health (2004) 1.13
Chronic non-cancer pain: a siren for primary care--a report from the PRImary Care MultiEthnic Network (PRIME Net). J Am Board Fam Med (2011) 1.11
Racial, gender, and socioeconomic status bias in senior medical student clinical decision-making: a national survey. J Gen Intern Med (2015) 1.11
Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med (2007) 1.09
Tendon friction rubs in early diffuse systemic sclerosis: prevalence, characteristics and longitudinal changes in a randomized controlled trial. Rheumatology (Oxford) (2010) 1.08
The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study. Arthritis Res Ther (2009) 1.08
Item response theory, computerized adaptive testing, and PROMIS: assessment of physical function. J Rheumatol (2013) 1.07
Child maltreatment prevalence and mental disorders outcomes among American Indian women in primary care. Child Abuse Negl (2004) 1.07
Web-based primary care referral program associated with reduced emergency department utilization. Fam Med (2006) 1.06
Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. Arthritis Care Res (Hoboken) (2012) 1.06
The impact of rheumatoid arthritis and treatment on patients' lives. Clin Exp Rheumatol (2010) 1.05
Interstitial lung disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 1.04
Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum (2010) 1.04
Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects. J Investig Med (2007) 1.04
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. Arthritis Care Res (Hoboken) (2014) 1.03
Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study. Arthritis Rheum (2010) 1.03
Functional implications of ipsilesional motor deficits after unilateral stroke. Arch Phys Med Rehabil (2005) 1.03
Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum (2011) 1.01
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis (2012) 1.00
Pregnancy outcomes in systemic sclerosis, primary pulmonary hypertension, and sickle cell disease. Obstet Gynecol (2008) 0.99
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis. Rheumatology (Oxford) (2010) 0.99
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis (2012) 0.98
A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum (2008) 0.98
Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) (2011) 0.97
GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci (2014) 0.96
Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol (2006) 0.96
Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trial. J Rheumatol (2011) 0.95
Regional variation in cardiovascular disease risk factors among American Indians and Alaska Natives with diabetes. Diabetes Care (2002) 0.95
Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot study. Arthritis Rheum (2009) 0.94
New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). Clin Exp Rheumatol (2012) 0.94
Understanding gastrointestinal distress: a framework for clinical practice. Am J Gastroenterol (2011) 0.92
Scleroderma--developing measures of response. J Rheumatol (2005) 0.92
Stress activation of cellular markers of inflammation in rheumatoid arthritis: protective effects of tumor necrosis factor alpha antagonists. Arthritis Rheum (2008) 0.92
Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas (2010) 0.91
Interaction between RANKL and HLA-DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis Rheum (2004) 0.91
Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel. Clin Exp Rheumatol (2010) 0.91
Clinical trial design in scleroderma: where are we and where do we go next? Clin Exp Rheumatol (2012) 0.91
Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol (2013) 0.91
Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol (2005) 0.90
Articular involvement in systemic sclerosis. Rheumatology (Oxford) (2012) 0.90
Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis (2007) 0.89
Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology (Oxford) (2010) 0.89
Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients. Qual Life Res (2006) 0.89
Become your own advocate: advice from women living with scleroderma. Disabil Rehabil (2007) 0.88
Acanthosis Nigricans: high prevalence and association with diabetes in a practice-based research network consortium--a PRImary care Multi-Ethnic network (PRIME Net) study. J Am Board Fam Med (2010) 0.88
Meloxicam in rheumatoid arthritis. Expert Opin Drug Metab Toxicol (2005) 0.87
Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) (2013) 0.87
Decentralized medical education in rural communities: the circuit rider connection. Fam Med (2008) 0.87
The shifting subtypes of ADHD: classification depends on how symptom reports are combined. J Abnorm Child Psychol (2008) 0.87
Changes in methadone maintenance therapy during and after pregnancy. J Subst Abuse Treat (2011) 0.87
Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials. Rheumatology (Oxford) (2010) 0.87